WASHINGTON, June 15, 2011 /PRNewswire-USNewswire/ -- A new ad campaign launched today highlights the clear choice Florida policymakers have in finding savings for the state's Medicaid program: cut benefits for patients or overpayments to independent drugstores. Florida could save $473 million over the next decade by cutting independent drugstore overpayments and modernizing its pharmacy benefits to be more like those in Medicare and commercial plans.
"Florida taxpayers shouldn't pay more for Medicaid drug benefits than Fortune 500 companies and Medicare," said Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt. "Currently, the program uses fewer generic drugs and pays drugstores almost double the fees that Medicare or private insurers pay. Over the next decade, Florida could save $473 million -- without cutting benefits or payments to doctors and hospitals -- by modernizing the program's pharmacy benefits."
Last month, Florida legislators voted to modernize the state's Medicaid program, including pharmacy benefits. Transitioning to a more efficient and affordable pharmacy benefit model would save states across the country billions without limiting access the National Center for Policy Analysis (NCPA) announced in a new white paper, "Increasing the Cost-Effectiveness of Medicaid Drug Programs."
Florida Medicaid pays too much for prescription drugs because the program uses an archaic, fee-for-service approach in which state officials set payment rates and are therefore constantly lobbied to inflate them by special interests like pharmacists. To avoid this trap, most non-Medicaid drug benefits programs -- like those offered by Medicare, employers and unions -- rely upo